JP2016510796A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016510796A5 JP2016510796A5 JP2015562211A JP2015562211A JP2016510796A5 JP 2016510796 A5 JP2016510796 A5 JP 2016510796A5 JP 2015562211 A JP2015562211 A JP 2015562211A JP 2015562211 A JP2015562211 A JP 2015562211A JP 2016510796 A5 JP2016510796 A5 JP 2016510796A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- het
- independently
- cycloalkyl
- halo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 125000000217 alkyl group Chemical group 0.000 claims 351
- 125000001475 halogen functional group Chemical group 0.000 claims 66
- 125000001424 substituent group Chemical group 0.000 claims 51
- -1 R 2 is -H Chemical group 0.000 claims 17
- 229910052757 nitrogen Inorganic materials 0.000 claims 17
- 125000000753 cycloalkyl group Chemical group 0.000 claims 13
- 150000001875 compounds Chemical class 0.000 claims 12
- 201000010099 disease Diseases 0.000 claims 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 12
- 150000001204 N-oxides Chemical class 0.000 claims 9
- 239000003814 drug Substances 0.000 claims 9
- 125000005842 heteroatom Chemical group 0.000 claims 9
- 239000002207 metabolite Substances 0.000 claims 9
- 229910052760 oxygen Inorganic materials 0.000 claims 9
- 239000000651 prodrug Substances 0.000 claims 9
- 229940002612 prodrug Drugs 0.000 claims 9
- 150000003839 salts Chemical class 0.000 claims 9
- 239000012453 solvate Substances 0.000 claims 9
- 229910052717 sulfur Inorganic materials 0.000 claims 9
- 229940124597 therapeutic agent Drugs 0.000 claims 9
- 230000000069 prophylactic effect Effects 0.000 claims 8
- 125000000623 heterocyclic group Chemical group 0.000 claims 6
- 125000005843 halogen group Chemical group 0.000 claims 3
- 125000003118 aryl group Chemical group 0.000 claims 2
- 125000001072 heteroaryl group Chemical group 0.000 claims 2
- 150000004677 hydrates Chemical class 0.000 claims 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims 2
- MJQSRSOTRPMVKB-UHFFFAOYSA-N 5h-imidazo[4,5-c]pyridazine Chemical group C1=NNC2=NC=NC2=C1 MJQSRSOTRPMVKB-UHFFFAOYSA-N 0.000 claims 1
- 208000009137 Behcet syndrome Diseases 0.000 claims 1
- 208000009766 Blau syndrome Diseases 0.000 claims 1
- 206010009900 Colitis ulcerative Diseases 0.000 claims 1
- 208000011231 Crohn disease Diseases 0.000 claims 1
- 102000004877 Insulin Human genes 0.000 claims 1
- 108090001061 Insulin Proteins 0.000 claims 1
- 108091000080 Phosphotransferase Proteins 0.000 claims 1
- 201000004681 Psoriasis Diseases 0.000 claims 1
- 208000034189 Sclerosis Diseases 0.000 claims 1
- 201000006704 Ulcerative Colitis Diseases 0.000 claims 1
- 206010046851 Uveitis Diseases 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- OGEBRHQLRGFBNV-RZDIXWSQSA-N chembl2036808 Chemical group C12=NC(NCCCC)=NC=C2C(C=2C=CC(F)=CC=2)=NN1C[C@H]1CC[C@H](N)CC1 OGEBRHQLRGFBNV-RZDIXWSQSA-N 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000000032 diagnostic agent Substances 0.000 claims 1
- 229940039227 diagnostic agent Drugs 0.000 claims 1
- 208000010758 granulomatous inflammation Diseases 0.000 claims 1
- 208000027866 inflammatory disease Diseases 0.000 claims 1
- 229940125396 insulin Drugs 0.000 claims 1
- 206010025135 lupus erythematosus Diseases 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 102000020233 phosphotransferase Human genes 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 201000000306 sarcoidosis Diseases 0.000 claims 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1304714.7 | 2013-03-15 | ||
| EPPCT/EP2013/066732 | 2013-03-15 | ||
| GBGB1304714.7A GB201304714D0 (en) | 2013-03-15 | 2013-03-15 | Macrocyclic RIP2 Kinase inhibitors |
| EP2013066732 | 2013-03-15 | ||
| PCT/EP2014/055139 WO2014140299A1 (en) | 2013-03-15 | 2014-03-14 | Macrocyclic rip2 kinase inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016510796A JP2016510796A (ja) | 2016-04-11 |
| JP2016510796A5 true JP2016510796A5 (OSRAM) | 2017-03-23 |
Family
ID=50342296
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015562211A Withdrawn JP2016510796A (ja) | 2013-03-15 | 2014-03-14 | 大環状ｒｉｐ２キナーゼ阻害剤 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20160024114A1 (OSRAM) |
| JP (1) | JP2016510796A (OSRAM) |
| KR (1) | KR20150133765A (OSRAM) |
| CN (1) | CN105228625A (OSRAM) |
| AU (1) | AU2014230111A1 (OSRAM) |
| BR (1) | BR112015022982A2 (OSRAM) |
| CA (1) | CA2906257A1 (OSRAM) |
| EA (1) | EA201591773A1 (OSRAM) |
| HK (1) | HK1218263A1 (OSRAM) |
| IL (1) | IL241250A0 (OSRAM) |
| MX (1) | MX2015012526A (OSRAM) |
| SG (1) | SG11201507594YA (OSRAM) |
| WO (1) | WO2014140299A1 (OSRAM) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016146651A1 (en) * | 2015-03-16 | 2016-09-22 | Oncodesign Sa | Macrocyclic activin-like receptor kinase inhibitors |
| EP3458072B1 (en) | 2016-05-19 | 2020-09-30 | Universiteit Antwerpen | Bis(acetamidophenyl) guanidinophenylethylphosphonates for use in the prevention and/or treatment of par-related diseases |
| CN109715165A (zh) * | 2016-07-28 | 2019-05-03 | Tp生物医药公司 | 巨环激酶抑制剂 |
| KR102719387B1 (ko) * | 2017-01-26 | 2024-10-21 | 한미약품 주식회사 | 이미다조피리다진 화합물 |
| JP7092405B2 (ja) * | 2018-04-16 | 2022-06-28 | 深▲チェン▼市塔吉瑞生物医薬有限公司 | キナーゼ活性を阻害するためのジ（ヘテロ）アリール大環状化合物 |
| KR102850357B1 (ko) | 2018-10-22 | 2025-08-27 | 알루미스 인크. | Tyk2 억제제 및 이의 용도 |
| MX2022009285A (es) * | 2020-01-31 | 2022-11-09 | Oncodesign Prec Medicine Opm | Inhibidores macrocíclicos de la quinasa rip2. |
| AU2023339247A1 (en) * | 2022-09-07 | 2025-03-27 | Suzhou Langrui Biopharmaceutical Co., Ltd. | Macrocyclic imidazo[1,2-b]pyridazine derivative, preparation method therefor, and use thereof |
| WO2025212514A2 (en) * | 2024-04-02 | 2025-10-09 | Interline Therapeutics, Inc. | Methods of treating inflammatory diseases |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPQ120999A0 (en) * | 1999-06-25 | 1999-07-22 | Industrial Automation Services Pty Ltd | Vibration suppressing piston |
| JP2004089182A (ja) * | 2002-06-24 | 2004-03-25 | Takeda Chem Ind Ltd | がんの予防・治療剤 |
| TWI547494B (zh) * | 2011-08-18 | 2016-09-01 | 葛蘭素史克智慧財產發展有限公司 | 作為激酶抑制劑之胺基喹唑啉類 |
| MX342177B (es) * | 2011-09-30 | 2016-09-20 | Ipsen Pharma Sas | Inhibidores de cinasa 2 de repeticion rica en leucina (lrrk2) macrociclica. |
| US9090630B2 (en) * | 2011-09-30 | 2015-07-28 | Oncodesign S.A. | Macrocyclic FLT3 kinase inhibitors |
| PL2970333T3 (pl) * | 2013-03-15 | 2017-12-29 | Oncodesign S.A. | Makrocykliczne inhibitory kinazy LRRK2 |
| JP2016510797A (ja) * | 2013-03-15 | 2016-04-11 | オンコデザイン エス．ア． | 大環状塩誘導性キナーゼ阻害剤 |
-
2014
- 2014-03-14 MX MX2015012526A patent/MX2015012526A/es unknown
- 2014-03-14 HK HK16106342.4A patent/HK1218263A1/zh unknown
- 2014-03-14 AU AU2014230111A patent/AU2014230111A1/en not_active Abandoned
- 2014-03-14 SG SG11201507594YA patent/SG11201507594YA/en unknown
- 2014-03-14 BR BR112015022982A patent/BR112015022982A2/pt not_active IP Right Cessation
- 2014-03-14 JP JP2015562211A patent/JP2016510796A/ja not_active Withdrawn
- 2014-03-14 CN CN201480023821.5A patent/CN105228625A/zh active Pending
- 2014-03-14 CA CA2906257A patent/CA2906257A1/en not_active Abandoned
- 2014-03-14 WO PCT/EP2014/055139 patent/WO2014140299A1/en not_active Ceased
- 2014-03-14 KR KR1020157029469A patent/KR20150133765A/ko not_active Withdrawn
- 2014-03-14 US US14/776,889 patent/US20160024114A1/en not_active Abandoned
- 2014-03-14 EA EA201591773A patent/EA201591773A1/ru unknown
-
2015
- 2015-09-07 IL IL241250A patent/IL241250A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016510796A5 (OSRAM) | ||
| JP2016510797A5 (OSRAM) | ||
| JP2019536785A5 (OSRAM) | ||
| JP2017529365A5 (OSRAM) | ||
| RU2014117515A (ru) | Макроциклические ингибиторы киназы lrrk2 | |
| JP6013375B2 (ja) | キナーゼ阻害剤としてのチアゾリルフェニル−ベンゼンスルホンアミド誘導体 | |
| JP2017511357A5 (OSRAM) | ||
| JP2019512505A5 (OSRAM) | ||
| JP2016531858A5 (OSRAM) | ||
| JP2016523270A5 (OSRAM) | ||
| WO2016097869A4 (en) | Fused ring heteroaryl compounds and their use as trk inhibitors | |
| RU2012148246A (ru) | 5, 7- замещенные-имидазо[1, 2-с]пиримидины как ингибиторы jak-киназ | |
| JP2016525136A5 (OSRAM) | ||
| JP2016506419A5 (OSRAM) | ||
| JP2012511588A5 (OSRAM) | ||
| CR20200418A (es) | Inhibidores de orginasa y sus mètodos de uso antecedentes | |
| JP2020527588A5 (OSRAM) | ||
| JP2018519323A5 (OSRAM) | ||
| JP2019522055A5 (OSRAM) | ||
| JP2009507032A (ja) | 新規なイミダゾ系複素環 | |
| RU2017120970A (ru) | Производные желчной кислоты в качестве агонистов fxr/tgr5 и способы их применения | |
| JP2018514518A5 (OSRAM) | ||
| JP2017503867A5 (OSRAM) | ||
| JP2014506599A5 (OSRAM) | ||
| JP2016530262A5 (OSRAM) |